Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer
Table 2
Transcripts found differentially expressed across all pairwise comparisons (top) and across normal versus primary tumor and primary tumor versus metastatic samples comparisons (bottom).
Transcript
Mean fold difference
P versus N
M versus P
M versus N
ACOT11-001
0.79
0.77
0.61
AOX1-001
0.79
0.56
0.44
C19orf46-002
1.24
1.23
1.53
C8orf84-001
0.76
0.75
0.57
COCH-202
0.76
0.83
0.63
CTA-55I10.1-001
0.83
0.68
0.56
DMD-024
0.74
0.82
0.60
FGF10-002
0.83
0.64
0.53
FGFR2-008
0.76
0.79
0.60
FGFR2-016
0.74
0.67
0.49
GABRE-006
0.79
0.83
0.66
GNAL-001
0.82
0.69
0.57
GNAO1-002
0.78
0.75
0.58
HEATR8-006
0.80
0.80
0.64
ISL1-002
0.80
0.81
0.65
NR2F2-202
0.82
0.82
0.68
PCP4-004
0.81
0.72
0.58
PDE5A-005
0.74
0.79
0.59
PDZRN4-202
0.80
0.71
0.57
RSRC2-017
1.27
1.28
1.63
TGM4-001
0.68
0.62
0.42
TSPAN2-001
0.80
0.77
0.61
ABCC4-004
1.35
0.81
N.A.
ALK-001
1.24
0.83
N.A.
ATP1A1-002
1.23
0.71
N.A.
NAMPT-006
1.34
0.73
N.A.
NAMPT-007
1.75
0.57
N.A.
RP11-627G23.1-004
1.38
0.78
N.A.
N: Normal, P: Primary and M: Metastatic samples. N.A.: not applicable.
